Simultaneous determination of prostaglandin E1, prostaglandin E0 and 15-keto-prostaglandin E0 in human plasma by gas chromatography/negative-ion chemical-ionization tandem mass spectrometry.
A sensitive and selective routine method for the simultaneous determination of prostaglandin E1 (PGE1), prostaglandin E0 (PGE0) and 15-keto-prostaglandin E0 (15-keto-PGE0) in human plasma is described using deuterated internal standards. The analytes were isolated from acidified human plasma by solid-phase extraction by means of Bond Elut C18 cartridges and derivatized to the pentafluorobenzyl (PFB) ester methoxime. The analytes were purified on Bond Elut Si cartridges and converted to the trimethylsilyl (TMS) ether. Quantitation was achieved by gas chromatography-negative-ion chemical-ionization tandem mass spectrometry. The precursor ion [M-PFB]- = [P]- carried more than 80% of the total ion current. Collision activated decomposition (CAD) of [P]- resulted in characteristic product ions of which the [P-2(CH3)3SiOH]- ion (PGE1) and the [P-(CH3)3SiOH]- ion (PGE0 and 15-keto-PGE0) were used for quantitation. The lower limit of quantitation (LLQ) was 2 pg/ml (PGE1 and PGE0) and 10 pg/ml (15-keto-PGE0) extracted from 2 ml of human plasma. Linear calibration curves were obtained over the concentration range 2-100 pg/ml (PGE1 and PGE0) and 10-500 pg/ml (15-keto-PGE0). In all cases, the precision and accuracy were < 17%. The present method has been applied successfully to pharmacokinetic and clinical studies in humans.
Hammes
W
W
Department of Bioanalytics, Schwarz Pharma AG, Monheim, Germany.
Büchsler
U
U
Kinder
P
P
Bökens
H
H
D002138:Calibration; D008401:Gas Chromatography-Mass Spectrometry / Q000379:methods*; D006801:Humans; D011458:Prostaglandins E / Q000097:blood*; D012015:Reference Standards; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
D011458:Prostaglandins E